We are live on
!
Find out more
GFA
Gifford Fong Associates Portfolio holdings
AUM
$501M
1-Year Est. Return
32.77%
This Fund
S&P 500
This Quarter
Est. Return
+12.08%
1 Year Est. Return
+32.77%
3 Year Est. Return
+180.45%
5 Year Est. Return
+217.25%
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$49.1M
(+11%)
Cap. Flow
-$143K
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
43.69%
Holding
136
New
1
Increased
2
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ford
F
|
+$1.99M |
| 2 |
Verizon
VZ
|
+$1.43M |
| 3 |
Organon & Co
OGN
|
+$75.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Resources
BEN
|
+$3.56M |
| 2 |
Merck
MRK
|
+$81.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.35% |
| 2 | Financials | 21.19% |
| 3 | Communication Services | 12.71% |
| 4 | Consumer Discretionary | 10.72% |
| 5 | Healthcare | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Union Pacific
UNP
$175B
| $5.06M | 0.98% |
23,000
| – | – |
|
27
Comcast
CMCSA
$90.4B
| $5.02M | 0.98% |
88,000
| – | – |
|
28
Invesco
IVZ
$13.9B
| $4.96M | 0.96% |
185,393
| – | – |
|
29
Pfizer
PFE
$150B
| $4.88M | 0.95% |
124,729
| – | – |
|
30
Emerson Electric
EMR
$91.4B
| $4.81M | 0.94% |
50,000
| – | – |
|
31
Johnson & Johnson
JNJ
$628B
| $4.76M | 0.93% |
28,900
| – | – |
|
32
GE Aerospace
GE
$379B
| $4.53M | 0.88% |
67,473
| – | – |
|
33
Boeing
BA
$183B
| $4.48M | 0.87% |
18,710
| – | – |
|
34
Pitney Bowes
PBI
$2.28B
| $4.48M | 0.87% |
511,059
| – | – |
|
35
Citigroup
C
$231B
| $4.35M | 0.85% |
61,471
| – | – |
|
36
Meta Platforms (Facebook)
META
$1.47T
| $4.35M | 0.84% |
12,500
| – | – |
|
37
AT&T
T
$166B
| $4.13M | 0.8% |
190,244
| – | – |
|
38
Wells Fargo
WFC
$269B
| $3.99M | 0.78% |
88,052
| – | – |
|
39
Biogen
BIIB
$30.9B
| $3.98M | 0.77% |
11,500
| – | – |
|
40
Eli Lilly
LLY
$1.09T
| $3.69M | 0.72% |
16,100
| – | – |
|
|
SIVB
41
DELISTED
SVB Financial Group
SIVB
| $3.34M | 0.65% |
6,000
| – | – |
|
|
WBA
42
DELISTED
Walgreens Boots Alliance
WBA
| $3.16M | 0.61% |
60,000
| – | – |
|
43
AbbVie
ABBV
$440B
| $3.14M | 0.61% |
27,900
| – | – |
|
|
44
Verizon
VZ
$195B
| $3.12M | 0.61% |
55,663
+25,000
| +82% | +$1.43M |
|
45
Honeywell
HON
$74.6B
| $3.09M | 0.6% |
14,960
| – | – |
|
46
Goldman Sachs
GS
$301B
| $3.04M | 0.59% |
8,000
| – | – |
|
47
Lowe's Companies
LOW
$121B
| $2.97M | 0.58% |
15,320
| – | – |
|
48
Bausch Health
BHC
$2.31B
| $2.93M | 0.57% |
100,000
| – | – |
|
49
Morgan Stanley
MS
$342B
| $2.75M | 0.53% |
30,000
| – | – |
|
|
MRO
50
DELISTED
Marathon Oil Corporation
MRO
| $2.52M | 0.49% |
184,728
| – | – |
|
Similar funds
HFA
VFPW
CIP
LRWA
VW
DE
MG
OP
Gifford Fong Associates's Q2 2021 Portfolio in Review
As of Q2 2021, Gifford Fong Associates held 136 positions worth $514M, up 11% from $465M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 1.5%. Gifford Fong Associates opened 1 new position and exited 1, leaving the 136-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Communication Services.
- Gifford Fong Associates's largest Q2 2021 buy was Organon & Co: 2,290 shares worth $69K.
- Gifford Fong Associates added most to Ford in Q2 2021, an estimated $1.99M increase.
- Gifford Fong Associates's biggest Q2 2021 reduction was Merck, cutting an estimated $81.7K.
- Gifford Fong Associates fully exited Franklin Resources in Q2 2021, selling an estimated $3.56M.
- Gifford Fong Associates's ten largest holdings make up 44% of its $514M portfolio in Q2 2021.
- Gifford Fong Associates opened 1 new position and closed 1 in Q2 2021.
- Gifford Fong Associates's portfolio value rose 11% quarter-over-quarter to $514M.
Based on Gifford Fong Associates's 13F filing for Q2 2021, filed 9 Aug 2021.